Drug Shortage Report for SANDOZ-DICLOFENAC
| Report ID | 274361 |
| Drug Identification Number | 02261928 |
| Brand name | SANDOZ-DICLOFENAC |
| Common or Proper name | DICLOFENAC |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | DICLOFENAC SODIUM |
| Strength(s) | 50MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL RECTAL |
| Packaging size | 30 |
| ATC code | M01AB |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2025-12-12 |
| Estimated end date | 2026-01-09 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-15 | French | Compare |
| v1 | 2025-12-15 | English | Compare |
Showing 1 to 2 of 2